Opinion: Medicare Should Cover Next-Generation Sequencing For Beneficiaries With Suspected Hereditary Cancer.

In an opinion piece for STAT (3/1), Roger Klein, the former medical director of molecular oncology at the Cleveland Clinic, writes that “next-generation sequencing, a technique that can read an individual’s entire genome in as little as an hour, has the p...